LYRA

Lyra Therapeutics (LYRA)

Lyra Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LYRA

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/06	20:59	GlobeNewswire Inc.	Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/05/01	05:04	GlobeNewswire Inc.	Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/04/27	05:51	GlobeNewswire Inc.	Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/03/22	05:01	GlobeNewswire Inc.	Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/03/02	06:01	GlobeNewswire Inc.	Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/02/15	23:18	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/02/15	10:35	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/02/15	08:18	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/02/15	06:51	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/02/15	06:18	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/02/14	06:34	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/02/02	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/02/02	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LYRA	Lyra Therapeutics Inc
2024/01/08	20:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/12/28	20:40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/12/19	06:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/11/17	07:00	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/11/14	07:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/11/08	06:23	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/11/08	06:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/11/08	06:01	GlobeNewswire Inc.	Lyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/11/07	21:00	GlobeNewswire Inc.	Lyra Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/10/16	20:00	GlobeNewswire Inc.	Lyra Therapeutics Announces Appointment of Ronan O’Brien as Chief Legal Officer	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/09/13	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/09/12	20:00	GlobeNewswire Inc.	Lyra Therapeutics Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220 for the Treatment of Chronic Rhinosinusitis (CRS) in Patients with Prior Ethmoid Sinus Surgery	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/09/06	21:00	GlobeNewswire Inc.	Lyra Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/09/02	05:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/09/02	05:01	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/08/29	20:00	GlobeNewswire Inc.	Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis	NASDAQ:LYRA	Lyra Therapeutics Inc
2023/08/26	05:15	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:LYRA	Lyra Therapeutics Inc